Edition:
United Kingdom

Brainstorm Cell Therapeutics Inc (BCLI.OQ)

BCLI.OQ on NASDAQ Stock Exchange Capital Market

3.14USD
15 Nov 2018
Change (% chg)

-- (--)
Prev Close
$3.14
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
9,995
52-wk High
$5.34
52-wk Low
$2.88

Chart for

About

Brainstorm Cell Therapeutics Inc. is a biotechnology company. The Company is engaged in developing adult stem cell therapies for debilitating neurodegenerative disorders, such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Multiple Sclerosis (MS) and Parkinson's disease (PD), among others. Its... (more)

Overall

Beta: 1.54
Market Cap(Mil.): $75.75
Shares Outstanding(Mil.): 18.84
Dividend: --
Yield (%): --

Financials

  BCLI.OQ Industry Sector
P/E (TTM): -- 83.95 33.59
EPS (TTM): -0.27 -- --
ROI: -52.76 -0.80 15.05
ROE: -52.76 -0.14 16.62

Earnings vs. Estimates